Oral Mucositis Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Galera Therapeutics, EpicentRx, Catalysis SL, Galera Therapeutics, Inc., UConn Health, Spherium Biomed, Izun Pharma Ltd, Soligenix, Onxe

DelveInsight's "Oral Mucositis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Oral Mucositis, historical and forecasted epidemiology as well as the Oral Mucositis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Oral Mucositis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Oral Mucositis Market Forecast
https://www.delveinsight.com/sample-request/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Oral Mucositis Market Report:
• The Oral Mucositis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Bell and Kasi (2023) report that individuals undergoing bone marrow transplantation or receiving heavy doses of chemotherapy have a 76% chance of developing mucositis. Patients who receive insufficient dental care and have low nutritional status are more likely to experience mucositis. Patients who are younger may experience more Oral Mucositis
• Pacheco et al. (2021) reported that the incidence of oral mucositis was 89.4% in patients receiving treatment for head and neck cancer. For mild, moderate, and severe degrees, the global incidence was 16.8%, 34.5%, and 26.4%, in that order
• About 30% to 40% of cancer patients overall have oral mucositis, according to research by Sonis et al
• According to Brown TJ et al. (2020), mucositis occurs in 20% to 40% of individuals with solid tumors taking chemotherapy. It typically appears five to fourteen days after the patient begins treatment
• Key Oral Mucositis Companies: Galera Therapeutics, EpicentRx, Catalysis SL, Galera Therapeutics, Inc., UConn Health, Spherium Biomed, Izun Pharma Ltd, Soligenix, Onxeo, Access Pharmaceuticals, Inc., CuraGen Corporation, Alizyme, RxKinetix, SIRO Clinpharm Private Limited, Celgene,Crystal Life Sciences, Andrulis Pharmaceuticals, SciClone Pharmaceuticals, and others
• Key Oral Mucositis Therapies: Avasopasem Manganese (GC4419), RRx-001, Oncoxin®, GC4419, celecoxib, Melatonin, IZN-6N4, SGX942, Clonidine Lauriad®, amlexanox, velafermin, CG53135-05, ATL-104, RK-0202, TK-112690, Apremilast, TK-112690, Thalidomide, SCV-07, and others
• The Oral Mucositis epidemiology based on gender analyzed that a significantly greater risk of OM has been found in women than in men, and their OM generally is more severe and lasts longer
• The Oral Mucositis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Oral Mucositis pipeline products will significantly revolutionize the Oral Mucositis market dynamics.

Oral Mucositis Overview
The extremely crippling disorder known as oral mucositis (OM) is typified by erythema, edema, and ulcerations of the oral mucosa.

Get a Free sample for the Oral Mucositis Market Report
https://www.delveinsight.com/report-store/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Oral Mucositis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Oral Mucositis Epidemiology Segmentation:
The Oral Mucositis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Oral Mucositis
• Prevalent Cases of Oral Mucositis by severity
• Gender-specific Prevalence of Oral Mucositis
• Diagnosed Cases of Episodic and Chronic Oral Mucositis

Download the report to understand which factors are driving Oral Mucositis epidemiology trends @ Oral Mucositis Epidemiology Forecast
https://www.delveinsight.com/sample-request/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Oral Mucositis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Oral Mucositis market or expected to get launched during the study period. The analysis covers Oral Mucositis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Oral Mucositis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Oral Mucositis Therapies and Key Companies
• Avasopasem Manganese (GC4419): Galera Therapeutics
• RRx-001: EpicentRx
• Oncoxin®: Catalysis SL
• GC4419: Galera Therapeutics, Inc.
• celecoxib: UConn Health
• Melatonin: Spherium Biomed
• IZN-6N4: Izun Pharma Ltd
• SGX942: Soligenix
• Clonidine Lauriad®: Onxeo
• amlexanox: Access Pharmaceuticals, Inc.
• velafermin: CuraGen Corporation
• CG53135-05: CuraGen Corporation
• ATL-104: Alizyme
• RK-0202: RxKinetix
• TK-112690: SIRO Clinpharm Private Limited
• Apremilast: Celgene
• TK-112690: Crystal Life Sciences
• Thalidomide: Andrulis Pharmaceuticals
• SCV-07: SciClone Pharmaceuticals

Discover more about therapies set to grab major Oral Mucositis market share @ Oral Mucositis Treatment Market
https://www.delveinsight.com/sample-request/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Oral Mucositis Market Strengths
• The rise in the incidence of Oral Mucositis (OM) has increased the research and development activities for developing Oral Mucositis drugs.

Oral Mucositis Market Unmet Needs
• Challenges in diagnosis
• Development of novel therapies
• The high cost of treatment
• Limited or no awareness about the disease

Scope of the Oral Mucositis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Oral Mucositis Companies: Galera Therapeutics, EpicentRx, Catalysis SL, Galera Therapeutics, Inc., UConn Health, Spherium Biomed, Izun Pharma Ltd, Soligenix, Onxeo, Access Pharmaceuticals, Inc., CuraGen Corporation, Alizyme, RxKinetix, SIRO Clinpharm Private Limited, Celgene,Crystal Life Sciences, Andrulis Pharmaceuticals, SciClone Pharmaceuticals, and others
• Key Oral Mucositis Therapies: Avasopasem Manganese (GC4419), RRx-001, Oncoxin®, GC4419, celecoxib, Melatonin, IZN-6N4, SGX942, Clonidine Lauriad®, amlexanox, velafermin, CG53135-05, ATL-104, RK-0202, TK-112690, Apremilast, TK-112690, Thalidomide, SCV-07, and others
• Oral Mucositis Therapeutic Assessment: Oral Mucositis current marketed and Oral Mucositis emerging therapies
• Oral Mucositis Market Dynamics: Oral Mucositis market drivers and Oral Mucositis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Oral Mucositis Unmet Needs, KOL's views, Analyst's views, Oral Mucositis Market Access and Reimbursement

To know more about Oral Mucositis companies working in the treatment market, visit @ Oral Mucositis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/oral-mucositis-om-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Oral Mucositis Market Report Introduction
2. Executive Summary for Oral Mucositis
3. SWOT analysis of Oral Mucositis
4. Oral Mucositis Patient Share (%) Overview at a Glance
5. Oral Mucositis Market Overview at a Glance
6. Oral Mucositis Disease Background and Overview
7. Oral Mucositis Epidemiology and Patient Population
8. Country-Specific Patient Population of Oral Mucositis
9. Oral Mucositis Current Treatment and Medical Practices
10. Oral Mucositis Unmet Needs
11. Oral Mucositis Emerging Therapies
12. Oral Mucositis Market Outlook
13. Country-Wise Oral Mucositis Market Analysis (2019-2032)
14. Oral Mucositis Market Access and Reimbursement of Therapies
15. Oral Mucositis Market Drivers
16. Oral Mucositis Market Barriers
17. Oral Mucositis Appendix
18. Oral Mucositis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Oral Mucositis Pipeline https://www.delveinsight.com/report-store/oral-mucositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Oral Mucositis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Oral Mucositis market. A detailed picture of the Oral Mucositis pipeline landscape is provided, which includes the disease overview and Oral Mucositis treatment guidelines.
Oral Mucositis Epidemiology https://www.delveinsight.com/report-store/oral-mucositis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Oral Mucositis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Oral Mucositis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Protein Supplements Market
https://www.delveinsight.com/report-store/protein-supplements-market
Protein Supplements Market By Source (Animal-Based [Whey, Casein, Fish, Eggs, Others], Plant-Based [Soy, Rice, Pea, Spirulina, Others]), By Product Type (Protein Powders, Protein Bars, Ready-To-Drink, And Others), By Application (Sports Nutrition And Functional Foods), By Distribution Channel (Supermarkets And Hypermarkets, E-Commerce, Direct-To-Consumer, Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to the growing consumer awareness of having a protein rich diet,

Proteomics Market
https://www.delveinsight.com/report-store/prostate-cancer-market-insight
Proteomics Market By Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, And Other], Reagents & Consumables, And Software & Services), By Application (Clinical Diagnostics, Drug Discovery, And Others), By End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028.

Infrared Thermometer Market
https://www.delveinsight.com/report-store/infrared-thermometer-market
Infrared Thermometer Market By Product Type (Contact Thermometers And Non-Contact Thermometers), By End-User (Food And Beverage Industry, Electronic Industry, Healthcare Industry, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing need for robust temperature measuring devices in critical industries and rise in the number of infectious diseases across the globe.

Hemoglobinopathies Market
https://www.delveinsight.com/report-store/sport-nutrition-market
Hemoglobinopathies Market By Indication (Thalassemia, Sickle Cell Anaemia, And Others), By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various hemoglobin disorders and the increasing research & developmental activities concerning to the hemoglobinopathies across the globe

Sport Nutrition Market
https://www.delveinsight.com/report-store/sport-nutrition-market
The Sports Nutrition Market By Product Type (Sports Drinks And Sports Supplements), By Distribution Channels (Hypermarkets & Supermarkets, E-Commerce, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing inclination toward following healthy and active lifestyle and growing importance of sports nutrition among athletes and sportspersons.

Endodontic Devices Market
https://www.delveinsight.com/report-store/endodontic-devices-market
Endodontic Devices Market By Product Type (Instruments [Apex Locators, Endodontic Motors, Endodontic Scalers, Endodontic Lasers, Handpieces, Machine-Assisted Obturation Systems, And Others], Consumables [Obturation, Access Cavity Preparation, Shaping And Cleaning]), By End-User (Dental Hospitals, Dental Clinics, And Others), and by geography is estimated to register growth at a remarkable CAGR during the forecast period from 2023-2028 owing to the rising patient pool associated with dental disorders, poor oral health, leading to increased number of root canal treatments, the increasing population opting for dental aesthetics, among others across the globe.

Chemotherapy Drugs Market https://www.delveinsight.com/report-store/chemotherapy-drugs-market
Chemotherapy Drugs Market By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By Route Of Administration (Oral And Parenteral), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increasing prevalence of different cancer types and increasing pharmaceutical trials for chemotherapy drugs.

Connected Drug Delivery Devices Market
https://www.delveinsight.com/report-store/connected-drug-delivery-devices-market
Connected Drug Delivery Devices Market By Product (Connected Sensors [Connected Inhaler Sensors And Connectable Injection Sensors] And Integrated Connected Devices [Connected Inhaler Devices And Connected Injection Devices], By Technology (Bluetooth, Near-Field Communication (NFC), And Others), By End-User (Healthcare Providers And Homecare), And by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of chronic diseases such as diabetes and improving healthcare it infrastructure across the globe.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.